Showing results (51-60 of 193) with videos related to
Sort By:
Pageof 20
BMC Infectious Diseases|August 28, 2020
Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapyPeng Peng, Yanjuan Xu, Michael W Fried, et al.Archives of Virology|November 20, 2019
In-depth serum virome analysis in patients with acute liver failure with indeterminate etiologyYi Ren, Yanjuan Xu, William M Lee, et al.Genome Medicine|February 25, 2011
Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogeneticsJohn E Tavis, Maureen J Donlin, Rajeev Aurora, et al.The Journal of General Virology|November 20, 2015
Evidence for deleterious hepatitis C virus quasispecies mutation loads that differentiate the response patterns in IFN-based antiviral therapyYi Ren, Weihua Wang, Xiaoan Zhang, et al.Antiviral Therapy|June 3, 2010
HIV-HBV coinfection among South African patients receiving antiretroviral therapyAdrian M Di Bisceglie, Mhairi Maskew, Doreen Schulze, et al.Expert Review of Gastroenterology & Hepatology|March 2, 2012
Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinomaRobert G Gish, Riccardo Lencioni, Adrian M Di Bisceglie, et al.Journal of Virology|October 5, 2012
Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytesSandip K Bose, Keith Meyer, Adrian M Di Bisceglie, et al.Journal of Virology|February 25, 2011
Transcriptional repression of C4 complement by hepatitis C virus proteinsArup Banerjee, Budhaditya Mazumdar, Keith Meyer, et al.Lipids in Health and Disease|November 13, 2020
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemiaAdrian M Di Bisceglie, Gerald F Watts, Philip Lavin, et al.The American Journal of Pathology|January 19, 2016
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular CarcinomaSourav Bhattacharya, Robert Steele, Shubham Shrivastava, et al.Pageof 20